Owkin raises €162.0M Series B round

The strategic investment aimed to advance precision medicine in oncology and helped Owkin reach unicorn status. The capital supports the discovery and development of treatments for four specific types of cancer.

Source: https://www.owkin.com/news/owkin-becomes-unicorn-with-180m-investment-from-sanofi